Newswise — Chicago, IL (March 1, 2016): Registration is open for the latest Emerging Issues in Oncology Webinar series featuring Updates from the San Antonio Breast Cancer Symposium (SABCS) on March 10 from 12:00 – 1:00 pm CST. The second in the series of Board Certified Oncology Pharmacy recertification opportunities presented by the Hematology/Oncology Pharmacy Association (HOPA) will explore recent and significant updates of interest to the pharmacist on the management of breast cancer patients. Detailed interpretation of important results presented at the Symposium this past December will be made with reference to previously published studies.
Dr. Meghana Trivedi, PharmD, PhD, BCOP, assistant professor at the University of Houston, College of Pharmacy will lead discussion covering hormone receptor-positive, HER2-positive, and triple-negative breast cancers separately to put the recent results in perspective with the current standard of care.
Following the live presentation, an audio recording of Updates from SABCS will be available as an online product for home study on-demand at any time. For more information, visit www.hoparx.org/bcop.
The Updates in Oncology Webinars series is part of the brand new educational programming HOPA has made available to help pharmacists fulfill their BCOP recertification needs. The five webinars presented throughout the year will review key findings from clinical and translational research, and data presented at national oncology meetings.
New this year, HOPA provides 38 credits of education per year including: Conference programming at the Annual Conference and just prior to the Oncology Pharmacy Practice Management Meeting September 22, a new 2-day live Updates Course July 15 – 16, 2016, and a downloadable self-study module available this summer.
HOPA is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This webinar will be available for 1 CH of ACPE and BCOP credit.
HOPA
HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has more than 2,400 members and includes oncology pharmacists, as well as pharmacy interns, residents, technicians, researchers, and administrators specializing in hematology/oncology practice.
RSS